From President & CEO, William Repicci

COVID-19 and the Lymphatic Disease Community

COVID-19 and the Lymphatic Disease Community

Dear friends and advocates,
 
With the advent of COVID-19, the world finds itself in the midst of a pandemic. Those with lymphatic disease understand this dynamic all too well. You have been living in the midst of a lymphedemic that has largely been ignored. However, thanks to our community’s

Read More >

Important information for LE and LD researchers from LE&RN

Important information for LE and LD researchers from LE&RN

Above photo: LE&RN President & CEO William Repicci (third from right) and Tim Padera, Ph.D. (far right) pictured with the staff of National Heart, Lung, Blood Institute (NHLBI).

Dear Lymphatic Researchers,

Growing the lymphatic research portfolio at the National

Read More >

2019 U.S. Senate Minibus Bill Update

2019 U.S. Senate Minibus Bill Update

Bill now includes "lymphatic research" in Committee recommendations

Dear LE&RN Supporting Members and other LE/LD Advocates,

TOGETHER we are making progress. 

The U.S. Senate just passed its second minibus bill, which now goes to the House. Assuming passage there, it will go to the

Read More >